Status:
COMPLETED
Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the usability of a novel patient portal intervention designed to: (a) notify patients when selected, clinically meaningful, evidence-based diabetes monitoring ...
Detailed Description
Up to 60 adult patients with type 1 or 2 diabetes mellitus will be enrolled and given access to a new feature within the patient portal at Vanderbilt University Medical Center. The new feature will be...
Eligibility Criteria
Inclusion
- Established patient at participating primary care clinic
- Type 1 or 2 diabetes mellitus
- Able to speak and read in English
- Age 18 to 75 years old
- Mobile device (smartphone or tablet) with internet access
- Active MHAV account and willing and able to use the MHAV native app on a mobile device
- Due (based on evidence-based guidelines) for any of the following: hemoglobin A1C, urine microalbumin, diabetes eye exam, and/or pneumococcal vaccination.
Exclusion
- Known cognitive deficits or functional impairment preventing the use of a mobile device
- Pregnant or planning to become pregnant during the study period
- Severe difficulty seeing
- Severe difficulty hearing
- Medical condition that make it hard for people to understand what they are saying
Key Trial Info
Start Date :
May 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04728620
Start Date
May 6 2021
End Date
May 25 2022
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212